THE RISKS OF CONCURRENT TREATMENT WITH TENOFOVIR AND AMINOGLYCOSIDES IN PATIENTS WITH HIV-ASSOCIATED TUBERCULOSIS

South Afr J HIV Med. 2011;12(1):43-45. doi: 10.4102/sajhivmed.v12i1.214.
No abstract available